文献速递乳腺MR

梯度回波波谱MRI测量乳腺脂肪组织脂肪酸组成及其与乳腺癌的关系

Fatty acid composition in mammary adipose tissue measured by Gradient-echo Spectroscopic MRI and its association with breast cancers.
PubMed 文献 · Eur J Radiol · 2019-05-01

研究纳入61例绝经后女性,在3T下行单侧梯度回波波谱成像,比较乳腺癌、良性/高危病变及有乳腺癌史三组乳腺脂肪组织脂肪酸组成。结果显示恶性肿瘤组饱和脂肪酸(SFA)显著高于良性病变组和有癌症史组,单不饱和脂肪酸(MUFA)显著低于两组。作者认为乳腺脂肪组织脂肪酸组成,尤其是较高SFA和较低MUFA,可能与乳腺癌相关。

要点

  • 乳腺癌组乳腺脂肪组织SFA为0.336±0.038,显著高于良性病变组0.283±0.046(p=0.0008)和有癌症史组0.287±0.050(p=0.0038)。
  • 乳腺癌组MUFA为0.352±0.041,显著低于良性病变组0.401±0.043(p=0.0032)和有癌症史组0.388±0.055(p=0.0484)。
  • GSI采用自动基于体素的分析测量脂肪酸组成,可能用于评估乳腺脂肪组织在癌症发生和进展中的作用。

核心结论

  • 乳腺脂肪组织脂肪酸组成,尤其是较高SFA和较低MUFA,可能与乳腺癌相关。
  • GSI方法利用自动基于体素的分析测量脂肪酸组成,可能用于评估乳腺脂肪组织在癌症发生和进展中的作用。

研究设计与样本

  • 研究为在3T下行单侧梯度回波波谱成像(GSI)的横断面研究,共纳入61例接受乳腺MRI检查的绝经后女性。
  • 研究包括19例乳腺癌女性、23例良性/高危病变女性和19例有癌症史女性。
  • 对每个体素进行脂肪酸波谱分析,测量单不饱和脂肪酸(MUFA)、多不饱和脂肪酸(PUFA)和饱和脂肪酸(SFA)的相对比例,自动选取乳腺脂肪组织内体素并以其中位脂肪酸分数进行定量分析。
  • 统计方法采用χ2检验、单因素方差分析(ANOVA)及Tukey-Kramer多重比较检验和线性回归。

诊断标准与关键数值

  • 乳腺癌组SFA为0.336±0.038,良性病变组为0.283±0.046(p=0.0008),有癌症史组为0.287±0.050(p=0.0038)。
  • 乳腺癌组MUFA为0.352±0.041,良性病变组为0.401±0.043(p=0.0032),有癌症史组为0.388±0.055(p=0.0484)。
  • 有癌症史组SFA与BMI显著相关(r=0.60,p=0.006),癌症组PUFA与BMI显著相关(r=0.57,p=0.010)。

临床应用与阅片要点

  • 作者认为乳腺脂肪组织脂肪酸组成,尤其是较高SFA和较低MUFA,可能与乳腺癌相关。
  • 作者认为GSI方法采用自动基于体素的分析测量脂肪酸组成,可能用于评估乳腺脂肪组织在癌症发生和进展中的作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the association of fatty acid levels in mammary adipose tissue of postmenopausal women with the presence of breast cancer using the Gradient-echo Spectroscopic Imaging (GSI).

MATERIALS AND METHODS: Unilateral GSI was performed at 3 T in 61 postmenopausal women undergoing breast MRI exams. The study included 19 women with breast cancer, 23 women with benign/high risk lesions, and 19 women with a history of cancer. Voxel-wise spectral analysis of fatty acids was conducted to measure relative portions of monounsaturated (MUFA), polyunsaturated (PUFA), and saturated fatty acids (SFA) in each voxel. The voxels within mammary adipose tissue were automatically selected and their median fatty acid fractions were used for quantitative analysis. Statistical analyses were performed using χ2 test, one-way analysis of variance (ANOVA) with Tukey-Kramer multiple comparison tests, and linear regression.

RESULTS: Postmenopausal women with malignancies had significantly higher SFA (0.336 ± 0.038) in mammary adipose tissue compared to those with benign disease (0.283 ± 0.046, p = 0.0008) and to those with a history of breast cancer (0.287 ± 0.050, p = 0.0038). Postmenopausal women with malignant lesions had significantly lower MUFA (0.352 ± 0.041) compared to those with benign disease (0.401 ± 0.043, p = 0.0032) and with history of breast cancer (0.388 ± 0.055, p = 0.0484). The history of cancer group had a significant correlation (r = 0.60, p = 0.006) between SFA and BMI, and the cancer group had a significant correlation (r = 0.57, p = 0.010) between PUFA and BMI.

CONCLUSIONS: Fatty acid composition of mammary adipose tissue, particularly higher SFA and lower MUFA, may be associated with breast cancer. The GSI method utilizes an automated voxel-based analysis to measure fatty acid composition, and may be used to assess the role of mammary adipose tissue in cancer development and progress.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Lewin AA, Storey P, Moccaldi M, et al. Fatty acid composition in mammary adipose tissue measured by Gradient-echo Spectroscopic MRI and its association with breast cancers. Eur J Radiol. 2019. PMID: 31153566. doi:10.1016/j.ejrad.2019.04.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。